IQVIA (IQV) Stock Forecast, Price Target & Predictions
IQV Stock Forecast
IQVIA stock forecast is as follows: an average price target of $269.43 (represents a 12.87% upside from IQV’s last price of $238.70) and a rating consensus of 'Buy', based on 12 wall street analysts offering a 1-year stock forecast.
IQV Price Target
The average price target for IQVIA (IQV) is $269.43 based on 1-year price targets from 12 Wall Street analysts in the past 3 months, with a price target range of $320.00 to $175.38. This represents a potential 12.87% upside from IQV's last price of $238.70.
IQV Analyst Ratings
According to 12 Wall Street analysts, IQVIA's rating consensus is 'Buy'. The analyst rating breakdown for IQV stock is 0 'Strong Buy' (0.00%), 10 'Buy' (83.33%), 2 'Hold' (16.67%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
IQVIA Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Aug 05, 2024 | Jonathan Block | Stifel Nicolaus | $175.38 | $236.24 | -25.76% | -26.53% |
| Jul 23, 2024 | Jailendra Singh | Truist Financial | $300.00 | $240.26 | 24.86% | 25.68% |
| Jul 23, 2024 | Elizabeth Anderson | Evercore ISI | $270.00 | $239.50 | 12.73% | 13.11% |
| Jul 23, 2024 | Luke Sergott | Barclays | $275.00 | $245.23 | 12.14% | 15.21% |
| Jun 18, 2024 | Justin Bowers | Deutsche Bank | $275.00 | $212.83 | 29.21% | 15.21% |
| Jun 13, 2024 | Eric Coldwell | Robert W. Baird | $241.00 | $217.46 | 10.82% | 0.96% |
| Jun 06, 2024 | Matthew Sykes | Goldman Sachs | $270.00 | $218.90 | 23.34% | 13.11% |
| Aug 02, 2022 | Elizabeth Anderson | Evercore ISI | $275.00 | $236.28 | 16.39% | 15.21% |
| May 12, 2022 | Jeff Garro | Piper Sandler | $255.00 | $202.53 | 25.91% | 6.83% |
| Apr 25, 2022 | - | Wells Fargo | $235.00 | $228.16 | 3.00% | -1.55% |
The latest IQVIA stock forecast, released on Aug 05, 2024 by Jonathan Block from Stifel Nicolaus, set a price target of $175.38, which represents a -25.76% decrease from the stock price at the time of the forecast ($236.24), and a -26.53% decrease from IQV last price ($238.70).
IQVIA Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | 5 | 7 |
| Avg Price Target | - | $259.08 | $258.05 |
| Last Closing Price | $238.70 | $238.70 | $238.70 |
| Upside/Downside | -100.00% | 8.54% | 8.11% |
In the current month, the average price target of IQVIA stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to IQVIA's last price of $238.70. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Sep 04, 2024 | RBC Capital | Outperform | Underperform | Initialise |
| Sep 03, 2024 | RBC Capital | - | Outperform | Initialise |
| Jul 24, 2024 | Jefferies | - | Hold | Downgrade |
| Jul 23, 2024 | Evercore ISI | Outperform | Outperform | Hold |
| Jul 23, 2024 | UBS | Buy | Buy | Hold |
| Jul 23, 2024 | Morgan Stanley | Overweight | Overweight | Hold |
| Jul 23, 2024 | Barclays | Overweight | Overweight | Hold |
| Jun 18, 2024 | Deutsche Bank | Buy | Buy | Hold |
| Jun 06, 2024 | Goldman Sachs | - | Buy | Initialise |
| Jan 25, 2024 | Truist Financial | Buy | Buy | Hold |
IQVIA's last stock rating was published by RBC Capital on Sep 04, 2024. The company Initialise its IQV rating from "Outperform" to "Underperform".
IQVIA Financial Forecast
IQVIA Revenue Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | $3.87B | $3.74B | $3.73B | $3.65B | $3.74B | $3.56B | - | $3.57B | $3.64B | $3.39B | $3.44B | $3.41B | $3.30B | $2.79B | $2.52B | $2.75B | $2.90B | $2.77B |
| Avg Forecast | $4.62B | $4.39B | $4.33B | $4.22B | $4.34B | $4.13B | $4.07B | $3.97B | $4.06B | $3.85B | $3.79B | $3.70B | $3.80B | $3.77B | $3.71B | $3.61B | $3.71B | $3.54B | $3.49B | $3.54B | $3.59B | $3.35B | $3.27B | $3.18B | $3.14B | $2.75B | $2.41B | $2.72B | $2.84B | $2.77B |
| High Forecast | $4.64B | $4.41B | $4.35B | $4.23B | $4.36B | $4.14B | $4.08B | $3.99B | $4.07B | $3.86B | $3.81B | $3.72B | $3.81B | $3.80B | $3.73B | $3.62B | $3.72B | $3.56B | $3.49B | $3.58B | $3.63B | $3.38B | $3.30B | $3.21B | $3.17B | $2.78B | $2.43B | $2.75B | $2.87B | $2.80B |
| Low Forecast | $4.60B | $4.37B | $4.31B | $4.20B | $4.32B | $4.11B | $4.05B | $3.96B | $4.04B | $3.84B | $3.77B | $3.69B | $3.79B | $3.75B | $3.69B | $3.59B | $3.69B | $3.53B | $3.49B | $3.50B | $3.55B | $3.31B | $3.23B | $3.14B | $3.10B | $2.72B | $2.38B | $2.69B | $2.81B | $2.74B |
| # Analysts | 6 | 6 | 12 | 11 | 10 | 9 | 8 | 7 | 8 | 13 | 6 | 4 | 8 | 15 | 9 | 9 | 13 | 13 | 6 | 6 | 7 | 7 | 7 | 5 | 5 | 5 | 5 | 5 | 4 | 4 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.02% | 0.99% | 1.01% | 1.01% | 1.01% | 1.01% | - | 1.01% | 1.01% | 1.01% | 1.05% | 1.07% | 1.05% | 1.01% | 1.05% | 1.01% | 1.02% | 1.00% |
IQVIA's average Quarter revenue forecast for Mar 24 based on 4 analysts is $3.70B, with a low forecast of $3.69B, and a high forecast of $3.72B. IQV's average Quarter revenue forecast represents a -4.23% decrease compared to the company's last Quarter revenue of $3.87B (Dec 23).
IQVIA EBITDA Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 6 | 6 | 12 | 11 | 10 | 9 | 8 | 7 | 8 | 13 | 6 | 4 | 8 | 15 | 9 | 9 | 13 | 13 | 6 | 6 | 7 | 7 | 7 | 5 | 5 | 5 | 5 | 5 | 4 | 4 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | $815.00M | $832.00M | $806.00M | $773.00M | $773.00M | $720.00M | - | $748.00M | $729.00M | $701.00M | $660.00M | $678.00M | $628.00M | $517.00M | $388.00M | $521.00M | $507.00M | $469.00M |
| Avg Forecast | $922.35M | $876.37M | $864.12M | $841.49M | $866.09M | $823.77M | $811.92M | $793.28M | $809.54M | $769.36M | $756.51M | $873.34M | $757.74M | $753.45M | $740.45M | $793.95M | $740.16M | $752.91M | $697.53M | $721.77M | $673.92M | $684.47M | $653.13M | $557.06M | $593.46M | $486.79M | $344.08M | $513.96M | $501.10M | $460.04M |
| High Forecast | $926.37M | $880.19M | $867.89M | $845.15M | $869.87M | $827.36M | $815.46M | $796.74M | $813.07M | $771.36M | $759.81M | $1.05B | $761.04M | $757.76M | $743.68M | $952.74M | $743.39M | $903.50M | $697.53M | $866.13M | $808.70M | $821.36M | $783.75M | $668.47M | $712.15M | $584.14M | $412.89M | $616.75M | $601.33M | $552.05M |
| Low Forecast | $918.81M | $873.01M | $860.81M | $838.26M | $862.77M | $820.62M | $808.81M | $790.24M | $806.43M | $767.36M | $753.61M | $698.68M | $755.74M | $748.18M | $737.61M | $635.16M | $737.33M | $602.33M | $697.53M | $577.42M | $539.14M | $547.57M | $522.50M | $445.65M | $474.77M | $389.43M | $275.26M | $411.17M | $400.88M | $368.03M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.08% | 1.10% | 1.09% | 0.97% | 1.04% | 0.96% | - | 1.04% | 1.08% | 1.02% | 1.01% | 1.22% | 1.06% | 1.06% | 1.13% | 1.01% | 1.01% | 1.02% |
4 analysts predict IQV's average Quarter EBITDA for Mar 24 to be $873.34M, with a high of $1.05B and a low of $698.68M. This is 7.16% upper than IQVIA's previous annual EBITDA (Dec 23) of $815.00M.
IQVIA Net Income Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 6 | 6 | 12 | 11 | 10 | 9 | 8 | 7 | 8 | 13 | 6 | 4 | 8 | 15 | 9 | 9 | 13 | 13 | 6 | 6 | 7 | 7 | 7 | 5 | 5 | 5 | 5 | 5 | 4 | 4 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | $469.00M | $303.00M | $297.00M | $289.00M | $227.00M | $283.00M | - | $325.00M | $317.00M | $261.00M | $175.00M | $212.00M | $119.00M | $101.00M | $-23.00M | $82.00M | $16.00M | $57.00M |
| Avg Forecast | $769.07M | $667.69M | $622.20M | $587.79M | $668.61M | $583.10M | $539.17M | $510.54M | $592.39M | $518.39M | $472.67M | $385.12M | $519.97M | $450.38M | $439.52M | $350.11M | $509.30M | $280.33M | $439.35M | $318.29M | $293.97M | $254.84M | $173.18M | $174.18M | $112.45M | $95.10M | $-20.40M | $80.89M | $15.81M | $55.91M |
| High Forecast | $773.43M | $671.47M | $625.72M | $591.12M | $672.40M | $586.41M | $542.23M | $513.44M | $595.74M | $522.08M | $475.35M | $462.15M | $523.66M | $459.61M | $442.01M | $420.14M | $512.18M | $336.39M | $439.35M | $381.94M | $352.77M | $305.81M | $207.81M | $209.02M | $134.95M | $114.12M | $-16.32M | $97.07M | $18.98M | $67.09M |
| Low Forecast | $765.24M | $664.36M | $619.10M | $584.86M | $665.28M | $580.20M | $536.48M | $508.00M | $589.43M | $511.01M | $470.32M | $308.10M | $516.28M | $433.76M | $437.33M | $280.09M | $506.76M | $224.26M | $439.35M | $254.63M | $235.18M | $203.88M | $138.54M | $139.35M | $89.96M | $76.08M | $-24.48M | $64.71M | $12.65M | $44.73M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.90% | 0.67% | 0.68% | 0.83% | 0.45% | 1.01% | - | 1.02% | 1.08% | 1.02% | 1.01% | 1.22% | 1.06% | 1.06% | 1.13% | 1.01% | 1.01% | 1.02% |
IQVIA's average Quarter net income forecast for Mar 24 is $385.12M, with a range of $308.10M to $462.15M. IQV's average Quarter net income forecast represents a -17.88% decrease compared to the company's last Quarter net income of $469.00M (Dec 23).
IQVIA SG&A Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 6 | 6 | 12 | 11 | 10 | 9 | 8 | 7 | 8 | 13 | 6 | 4 | 8 | 15 | 9 | 9 | 13 | 13 | 6 | 6 | 7 | 7 | 7 | 5 | 5 | 5 | 5 | 5 | 4 | 4 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | $556.00M | $502.00M | $482.00M | $513.00M | $583.00M | $517.00M | - | $488.00M | $542.00M | $498.00M | $482.00M | $442.00M | $491.00M | $460.00M | $431.00M | $723.00M | $798.00M | $694.00M |
| Avg Forecast | $680.07M | $646.17M | $637.14M | $620.45M | $638.59M | $607.39M | $598.65M | $584.91M | $596.89M | $567.27M | $557.80M | $578.28M | $558.70M | $555.54M | $545.95M | $525.71M | $545.74M | $534.88M | $514.31M | $477.92M | $501.05M | $486.25M | $476.98M | $363.16M | $464.00M | $433.12M | $382.21M | $713.23M | $788.72M | $680.74M |
| High Forecast | $683.03M | $648.98M | $639.92M | $623.15M | $641.37M | $610.04M | $601.26M | $587.46M | $599.49M | $568.74M | $560.23M | $693.94M | $561.14M | $558.71M | $548.33M | $630.85M | $548.12M | $641.86M | $514.31M | $573.50M | $601.26M | $583.51M | $572.38M | $435.79M | $556.79M | $519.74M | $458.65M | $855.88M | $946.47M | $816.89M |
| Low Forecast | $677.46M | $643.69M | $634.70M | $618.07M | $636.14M | $605.06M | $596.35M | $582.67M | $594.60M | $565.79M | $555.66M | $462.62M | $557.23M | $551.65M | $543.86M | $420.57M | $543.65M | $427.90M | $514.31M | $382.33M | $400.84M | $389.00M | $381.58M | $290.53M | $371.20M | $346.49M | $305.77M | $570.58M | $630.98M | $544.59M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.00% | 0.90% | 0.88% | 0.98% | 1.07% | 0.97% | - | 1.02% | 1.08% | 1.02% | 1.01% | 1.22% | 1.06% | 1.06% | 1.13% | 1.01% | 1.01% | 1.02% |
IQVIA's average Quarter SG&A projection for Mar 24 is $578.28M, based on 4 Wall Street analysts, with a range of $462.62M to $693.94M. The forecast indicates a 4.01% rise compared to IQV last annual SG&A of $556.00M (Dec 23).
IQVIA EPS Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 6 | 6 | 12 | 11 | 10 | 9 | 8 | 7 | 8 | 13 | 6 | 4 | 8 | 15 | 9 | 9 | 13 | 13 | 6 | 6 | 7 | 7 | 7 | 5 | 5 | 5 | 5 | 5 | 4 | 4 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | $2.55 | $1.66 | $1.61 | $1.56 | $1.22 | $1.52 | - | $1.71 | $1.66 | $1.36 | $0.91 | $1.11 | $0.62 | $0.53 | $-0.12 | $0.43 | $0.09 | $0.29 |
| Avg Forecast | $4.17 | $3.62 | $3.38 | $3.19 | $3.63 | $3.16 | $2.93 | $2.77 | $3.21 | $2.81 | $2.56 | $2.49 | $2.82 | $2.44 | $2.38 | $2.41 | $2.76 | $2.39 | $2.38 | $2.42 | $2.43 | $2.12 | $2.07 | $1.86 | $2.00 | $1.52 | $1.06 | $1.48 | $1.72 | $1.57 |
| High Forecast | $4.20 | $3.64 | $3.40 | $3.21 | $3.65 | $3.18 | $2.94 | $2.79 | $3.23 | $2.83 | $2.58 | $2.50 | $2.84 | $2.49 | $2.40 | $2.42 | $2.78 | $2.40 | $2.38 | $2.45 | $2.47 | $2.15 | $2.10 | $1.88 | $2.03 | $1.54 | $1.07 | $1.50 | $1.74 | $1.60 |
| Low Forecast | $4.15 | $3.60 | $3.36 | $3.17 | $3.61 | $3.15 | $2.91 | $2.76 | $3.20 | $2.77 | $2.55 | $2.48 | $2.80 | $2.35 | $2.37 | $2.40 | $2.75 | $2.38 | $2.38 | $2.38 | $2.40 | $2.09 | $2.04 | $1.83 | $1.97 | $1.49 | $1.04 | $1.46 | $1.69 | $1.55 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.90% | 0.68% | 0.68% | 0.65% | 0.44% | 0.64% | - | 0.71% | 0.68% | 0.64% | 0.44% | 0.60% | 0.31% | 0.35% | -0.11% | 0.29% | 0.05% | 0.18% |
According to 4 Wall Street analysts, IQVIA's projected average Quarter EPS for Mar 24 is $2.49, with a low estimate of $2.48 and a high estimate of $2.50. This represents a -2.43% decrease compared to IQV previous annual EPS of $2.55 (Dec 23).
IQVIA Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| CRL | Charles River Laboratories | $198.61 | $324.46 | 63.37% | Buy |
| LH | Laboratory Corporation of America | $221.13 | $287.00 | 29.79% | Buy |
| MEDP | Medpace | $351.67 | $444.20 | 26.31% | Buy |
| QGEN | Qiagen | $46.36 | $52.37 | 12.96% | Buy |
| IQV | IQVIA | $238.70 | $269.43 | 12.87% | Buy |
| NEOG | Neogen | $16.13 | $17.50 | 8.49% | Buy |
| ICLR | ICON Public Limited Company | $300.00 | $307.63 | 2.54% | Buy |
| RVTY | Revvity | $122.03 | $123.83 | 1.48% | Hold |
| WAT | Waters | $325.86 | $325.00 | -0.26% | Buy |
| MTD | Mettler-Toledo | $1.38K | $1.36K | -1.35% | Hold |
| IDXX | IDEXX Laboratories | $500.55 | $479.75 | -4.16% | Buy |
| TWST | Twist Bioscience | $46.95 | $41.20 | -12.25% | Buy |
IQV Forecast FAQ
Is IQVIA a good buy?
Yes, according to 12 Wall Street analysts, IQVIA (IQV) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 10 'Buy' recommendations, accounting for 83.33% of IQV's total ratings.
What is IQV's price target?
IQVIA (IQV) average price target is $269.43 with a range of $175.38 to $320, implying a 12.87% from its last price of $238.7. The data is based on 12 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will IQVIA stock go up soon?
According to Wall Street analysts' prediction for IQV stock, the company can go up by 12.87% (from the last price of $238.7 to the average price target of $269.43), up by 34.06% based on the highest stock price target, and down by -26.53% based on the lowest stock price target.
Can IQVIA stock reach $400?
IQV's average twelve months analyst stock price target of $269.43 does not support the claim that IQVIA can reach $400 in the near future.
What are IQVIA's analysts' financial forecasts?
IQVIA's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $16.51B (high $16.58B, low $16.44B), average EBITDA is $3.3B (high $3.31B, low $3.28B), average net income is $2.3B (high $2.31B, low $2.29B), average SG&A $2.43B (high $2.44B, low $2.42B), and average EPS is $12.49 (high $12.56, low $12.43). IQV's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $17.55B (high $17.63B, low $17.49B), average EBITDA is $3.5B (high $3.52B, low $3.49B), average net income is $2.65B (high $2.66B, low $2.63B), average SG&A $2.58B (high $2.6B, low $2.57B), and average EPS is $14.36 (high $14.44, low $14.29).
Did the IQV's actual financial results beat the analysts' financial forecasts?
Based on IQVIA's last annual report (Dec 2023), the company's revenue was $14.98B, beating the average analysts forecast of $14.89B by 0.66%. Apple's EBITDA was $3.26B, beating the average prediction of $3.05B by 6.91%. The company's net income was $1.36B, missing the average estimation of $1.76B by -22.84%. Apple's SG&A was $2.05B, missing the average forecast of $2.19B by -6.08%. Lastly, the company's EPS was $7.39, missing the average prediction of $10.06 by -26.53%. In terms of the last quarterly report (Dec 2023), IQVIA's revenue was $3.87B, beating the average analysts' forecast of $3.8B by 1.91%. The company's EBITDA was $815M, beating the average prediction of $757.74M by 7.56%. IQVIA's net income was $469M, missing the average estimation of $519.97M by -9.80%. The company's SG&A was $556M, missing the average forecast of $558.7M by -0.48%. Lastly, the company's EPS was $2.55, missing the average prediction of $2.82 by -9.62%